Key Financial’s Spectrum Pharmaceuticals SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,500
Closed -$2.4K – 1411
2023
Q2
$2.4K Hold
2,500
– – ﹤0.01% 1141
2023
Q1
$1.88K Hold
2,500
– – ﹤0.01% 965
2022
Q4
$1.08K Hold
2,500
– – ﹤0.01% 1023
2022
Q3
$1K Hold
2,500
– – ﹤0.01% 1103
2022
Q2
$2K Hold
2,500
– – ﹤0.01% 976
2022
Q1
$3K Hold
2,500
– – ﹤0.01% 900
2021
Q4
$3K Hold
2,500
– – ﹤0.01% 800
2021
Q3
$5K Buy
+2,500
New +$6.83K ﹤0.01% 723

Key Financial's SPPI Position: Q3 2023 in Review

Key Financial sold out of Spectrum Pharmaceuticals (SPPI) in Q3 2023, closing a stake of 2,500 shares — an estimated $2.4K sold.

Key Financial first reported a position in SPPI in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q3 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Key Financial reported no remaining Spectrum Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Key Financial sold 2,500 Spectrum Pharmaceuticals shares in Q3 2023, an estimated $2.4K.
  • Key Financial first reported a position in Spectrum Pharmaceuticals in Q3 2021 and held it in 8 quarters.
  • Key Financial's Spectrum Pharmaceuticals position peaked at $5K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals as of Q3 2023.

Based on Key Financial's 13F filing for Q3 2023, filed 1 Nov 2023.